Cubist Systematic Strategies, LLC Dice Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $1.54 Million - $2.78 Million	59,557 New	59,557 $2.77 Million
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $66,411 - $111,273	-5,035 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $134,276 - $231,059	-9,235 Reduced 64.72%	5,035 $96,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $319,790 - $535,695	14,270 New	14,270 $361,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.